Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 5, 1996 - Issue 10
Submit an article Journal homepage
16
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Editorial: Central & Peripheral Nervous Systems: Cannabinoid receptor ligands: clinical and neuropharmacological considerations relevant to future drug discovery and development

Roger G Pertwee Department of Biomedical Sciences, Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen, Scotland, AB25 2ZD, UK
Pages 1245-1253 | Published online: 03 Mar 2008

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Roger G Pertwee. (2000) Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opinion on Investigational Drugs 9:7, pages 1553-1571.
Read now
Francis Barth. (1998) Cannabinoid receptor agonists and antagonists. Expert Opinion on Therapeutic Patents 8:3, pages 301-313.
Read now

Articles from other publishers (4)

Roger G Pertwee. (1999) Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sciences 65:6-7, pages 597-605.
Crossref
Roger G. Pertwee. 1999. Marihuana and Medicine. Marihuana and Medicine 177 185 .
S J MacLennan, P H Reynen, J Kwan & D W Bonhaus. (2009) Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB 1 and CB 2 receptors . British Journal of Pharmacology 124:4, pages 619-622.
Crossref
Susanthi R. Fernando & Roger G. Pertwee. (1997) Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist. British Journal of Pharmacology 121:8, pages 1716-1720.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.